Scorpius Holdings, Inc.
已退市CIK 1476963fmd_1FZ57MY8TPKJF2CGN5YB6C7Q3M制造业 · 医药制剂模板: 标准
覆盖范围: 2009年1月01日 至 2025年9月30日，共 57 个期间
| 项目 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | – | 0 | 2 | 6 | 3 | 3 | 2 | 0 | 7 | 6 |
| 利息收入合计 | – | – | – | – | – | – | – | – | – | – |
| 净利息收入 | – | – | – | – | – | – | – | 1 | – | – |
| 营业成本 | – | – | – | – | – | – | – | 0 | 3 | 3 |
| 毛利润 | – | – | – | – | – | – | – | 0 | 4 | 3 |
| 研发费用 | 17 | 9 | 8 | 16 | 13 | 13 | 16 | 20 | 20 | 14 |
| 销售、一般及管理费用 | – | – | – | – | – | – | – | 20 | 26 | 22 |
| 营业费用合计 | 21 | 13 | 15 | 24 | 24 | 29 | 38 | – | – | – |
| 营业利润 | (21) | (13) | (13) | (18) | (21) | (26) | (35) | (40) | (42) | (34) |
| 利息费用 | 0 | 1 | – | – | – | – | – | – | – | – |
| 利息及投资收益 | 0 | – | – | – | – | – | – | – | – | – |
| 其他营业外收入（支出） | (0) | 0 | 0 | 0 | 0 | (0) | (0) | (1) | (0) | (1) |
| 税前利润 | – | (13) | (13) | (18) | (20) | (26) | (36) | (42) | (42) | (34) |
| 所得税费用 | – | – | (1) | (1) | 0 | – | (0) | (0) | (1) | – |
| 持续经营净利润 | – | – | (12) | (17) | (20) | – | (35) | (41) | (42) | (34) |
| 净利润 | (20) | (13) | (12) | (16) | (20) | (26) | (35) | (43) | (45) | (33) |